2/4
Nr opisu: rovides sufficient phe for maintenance and growth plus special phe-free formulas with amino acids to meet requirements for protein, energy and micronutrients. Rules for predicting phenylalanine tolerance changes during the course of pregnancy are not clear. The purpose of this report is to describe phe tolerance in pregnant PKU patients with the PAH genotype p.R408W/p.R408W. Low-phe diet was started before the pregnancies. the reviewed cases included three PKU women with two pregnancies and four PKU women with one pregnancy. Phe restriction in a patient's diet was determined upon the amount of this amino acid intake, which allows for stable blood phe concentrations within the target range of 120-360ľmol/L. Daily phe tolerance increased from 344ą85mg in the pre-conceptional period up to 1348ą446mg at the end of the third trimester. Before delivery, the lowest and highest phe tolerance expressed per kg of the pregnant women's body weight were 6.8 mg and 26.9 mg respectively. Phe tolerance varies greatly even between pregnancies of patients with the same PKU genotype. Further researc Autorzy: , . Tytuł pracy: Charakterystyka merytoryczna: Język publikacji: , women's body weight were 6.8 mg and 26.9 mg respectively. Phe tolerance varies greatly even between pregnancies of patients with the same PKU genotype. Further research on pregnant PKU patients is essential to identify biological regulators of phe tolerance during pregnancy and provide evidence-based guidelines to optimise the dietetic care.^aphenylalanine tolerance^apregnancy Wskaźnik Impact Factor ISI: Punktacja ministerstwa: Praca recenzowana Słowa kluczowe ang.: n's body weight were 6.8 mg and 26.9 mg respectively. Phe tolerance varies greatly even between pregnancies of patients with the same PKU genotype. Further research on pregnant PKU patients is essential to identify biological regulators of phe tolerance during pregnancy and provide evidence-based guidelines to optimise the dietetic care.^aphenylalanine tolerance^apregnancy Słowa kluczowe ang.: ;
3/4
Nr opisu: Tytuł pracy: Szczegóły: Tytuł monografii: Archiwum: Charakterystyka formalna: Charakterystyka merytoryczna: Język publikacji: Wskaźnik Impact Factor ISI: czynnikami wpływającymi na homeostazę Phe w ciąży u chorych na fenyloketonurię.^afenyloketonuria^aphenylketonuria^aThe maternal phenylketonuria (PKU) syndrome is caused by high phenylalanine (Phe) level during pregnancy. Dietary treatment to control Phe concentration (low-Phe diet) can prevent sequelae like intellectual disability, microcephaly and birth defects. In this study, 2 singleton pregnancies resulting in healthy offspring in one woman with phenylketonuria are reported. A state of metabolic control was sustained both during the preconception period and pregnancy in the course of both pregnancies. In clinical practice, the empirical determination of Phe tolerance relies on frequent assessment of blood Phe concentrations in patients with PKU in relation to Phe intake assessed using food records. In contrast to predictions based on literature data stating that Phe tolerance intensively increases in the third trimester and a low Phe tolerance may indicate fetal PKU, Phe tolerance in both pregnancies showed a low increase in the third trimester and a more noticeable increase during the whole pregnancy: 453 mg (30.2%)/1653 mg (551%) and 200 mg (12.5%)/1560 mg (650%), respectively. Interestingly, the patterns of Phe increase were relatively similar only in the second half of pregnancy. Further research on determinants of Phe tolerance in pregnant women with PKU is needed.^atolerancja fenyloalaniny^aphenylalanine tolerance^aoddziaływania matczyno-płodowe^amaternal-fetal interactions Praca recenzowana Słowa kluczowe: Słowa kluczowe ang.: DOI: Streszczenie: Streszczenie:
4/4
Tytuł czasopisma: Tytuł monografii: Charakterystyka wg MNiSW: Słowa kluczowe ang.: Słowa kluczowe ang.: Streszczenie: